Aligos Therapeutics Inc. (ALGS): Price and Financial Metrics
ALGS Price/Volume Stats
| Current price | $34.24 | 52-week high | $46.80 |
| Prev. close | $31.61 | 52-week low | $6.76 |
| Day low | $31.50 | Volume | 222,900 |
| Day high | $34.34 | Avg. volume | 390,055 |
| 50-day MA | $28.75 | Dividend yield | N/A |
| 200-day MA | $17.48 | Market Cap | 122.85M |
ALGS Stock Price Chart Interactive Chart >
Aligos Therapeutics Inc. (ALGS) Company Bio
Aligos Therapeutics, Inc. develops targeted, curative therapies for hepatologic diseases and viral infections. It engages in building a pipeline of drug candidates which targets multiple clinically validated mechanisms of action and are designed to achieve functional cure for CHB and become transformative treatment options for COVID-19 and NASH. The company was founded by Lucinda Quan and Lawrence M. Blatt on February 05, 2018 and is headquartered in South San Francisco, CA.
ALGS Price Returns
| 1-mo | -14.06% |
| 3-mo | 374.90% |
| 6-mo | 153.63% |
| 1-year | 101.15% |
| 3-year | -54.80% |
| 5-year | N/A |
| YTD | -14.06% |
| 2024 | 140.00% |
| 2023 | -30.32% |
| 2022 | -91.97% |
| 2021 | -57.07% |
| 2020 | N/A |
Loading social stream, please wait...